NCT05225805 - Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

September 20, 2022

Study Completion Date

January 13, 2023

Conditions

Cystic Fibrosis

Interventions

DRUG

Lefamulin

Antibiotic

Trial Locations (6)

New York Medical College, Valhalla

Penn State University College of Medicine, Hershey

University Hospitals Cleveland Medical Center, Cleveland

University of Kansas School of Medicine, Kansas City

University of Utah, Salt Lake City

Boston Children's Hospital, Boston